Delivery Order SPE2DB22D1103-SPE2DB24FTNG6

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is a delivery order with a ceiling value of $29,627.79. The contract, awarded by the Defense Logistics Agency (DLA), is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed price agreement with a final completion date of July 10, 2024. This award is not associated with a set-aside designation. Amerisourcebergen...
This federal contract award, valued at $1,720.98, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The award is for the delivery of 4564543426 MULTAQ 400 MG TABLET 60S and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $13,093.98 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MULTAQ 400 MG TABLET 60S, with a completion date of July 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $6,640.85 and an ultimate completion date of May 28, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,984.37 firm fixed-price delivery order is for the drug MULTAQ 400 MG TABLET 60S, with an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA). The $4,871.11 firm-fixed-price delivery order contract has a completion date of July 24, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of 4,565,391,887 units of the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $7,928.73 and a completion date of August 9, 2024. This appears to be a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides for the delivery of the pharmaceutical product MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,815.20 and runs through June 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of the pharmaceutical product MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $7,277.44, has a completion date of May 1, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,461.37, is a delivery order under the DLA's Indefinite Delivery Contract (IDC) for a range of medical products, including the MULTAQ 400 MG TABLET 60S. The IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive array...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTNG6
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, with a ceiling value of $7,154.40, is for the delivery of MULTAQ 400 MG TABLET 60S pharmaceutical products. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 10/8/24, 9:22 AM